Minimize Uncertainty – Make Informed Decisions – Succeed

Cardiovascular

Cardiovascular Today—December 18, 2025

December 18, 2025Lerodalcibep,Lerochol,BioPharma and Tech News,Atrial fibrillation,Cardiovascular News,Ketamine,Etomidate,Paroxysmal supraventricular tachycardia,Uterine fibroids,Atherosclerotic cardiovascular disease risk,Anthracycline induced cardiotoxicity,Dyslipidemia,Etiprimal,Echocardiography monitoringOral anticoagulation therapy,In vivo CRISPR editing

This week’s cardiovascular update brings together the latest trial results,…

by LucidQuest

Rare Disease news

Rare Disease Today—December 18, 2025

December 18, 2025gene therapy,Amgen,Fabry Disease,BioPharma and Tech News,Thyroid Eye Disease,Rare Disease News,CAR T cell therapy,generalized myasthenia gravis,CDKL5 deficiency disorderstiff person syndrome,argenx

This week’s rare disease update spotlights key developments, regulatory…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Today—December 18, 2025

December 18, 2025gene therapy,Cell Therapy,BioPharma and Tech News,Parkinson's Disease,CAR T Therapy,stem cell therapy,Cell and Gene Therapy News,Wiskott Aldrich syndrome,stiff person syndromeNeuron replacement therapy,Cytokine release syndrome

This week’s Cell & Gene Therapy update highlights major developments,…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Harbour BioMed and BMS collaboration on next-gen multi-specific antibodies

December 18, 2025immunotherapy,biopharma,BMS,Lucid Diligence Brief,diligence,T-cell engager,antibody discovery,Harbour BioMed,licensing deal,HBICEbiotech investment

Lucid Diligence Brief: Harbour BioMed and BMS collaboration on next-gen…

by Timos Papagatsias

Neuroscience

Neuroscience Today — December 17, 2025

December 17, 2025Charcot Marie Tooth disease type 2S,Congenital disorder of glycosylation,multiple sclerosis,Astrocytoma,Alzheimer's Disease,Formation Bio,Huntington's disease,Bleecker Bio,BioPharma and Tech News,Cycle Pharma,Parkinson's Disease,Anavex,CHMP,NeuraLight,Biogen,NeOnc Technologies,Neuroscience News,amyotrophic lateral sclerosis,Major depressive disorder,Applied Therapeutics,galactosemiaLynk Pharmaceuticals,Central nervous system diseases

This week’s Neuroscience update features regulatory decisions, pipeline…

by LucidQuest

Immunology

Immunology Video Recap—December 17, 2025

December 17, 2025NAV-240,TNFα,novartis,FT819,BioPharma and Tech News,iPSC CAR T,ZEVASKYN,Barinthus Biotherapeutics,hidradenitis suppurativa,Arcus Biosciences,ITP,OX40L,SLE,Immunology News,Ascletis Pharma,Abeona Therapeutics,ianalumab,CONMEDNavigator Medicines,Fate Therapeutics

This biweekly video brings you key highlights from across the immunology…

by LucidQuest

Immunology

Immunology Today—December 17, 2025

December 17, 2025novartis,BioPharma and Tech News,psoriasis,ITP,TYK2 inhibitor,Immunology News,celiac disease,EULAR,Immune thrombocytopeniaIL-17 inhibitor,adult-onset Still’s disease

This week in immunology: the latest clinical updates, industry progress, and…

by LucidQuest

Artificial_Intelligence

AI in Healthcare and Digital Health Video Recap —December 17, 2025

December 17, 2025Google,BioPharma and Tech News,Eli Lilly,Microsoft,OpenAI,European Commission,MHRA,AI in Healthcare and Digital Health,nvidia,michael burryHSA,Science Corp

Here’s your biweekly AI in Healthcare and Digital Health video brief covering…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Sanofi and ADEL sign global licensing deal in Alzheimer's

December 17, 2025clinical trials,neurology,Alzheimer's Disease,Regulatory,sanofi,biopharma,licensing,Lucid Diligence Brief,payer access,diligence,Monoclonal antibodiestau

Lucid Diligence Brief: Sanofi and ADEL sign global licensing deal in…

by Timos Papagatsias

Endocrinology

Endocrinology Video Recap—December 16, 2025

December 16, 2025LUMC,Wellgistics,wegovy,Debio 4126,BioPharma and Tech News,Technosphere insulin,obesity,INHALE 1 study,Novo Nordisk,Brenzavvy,Mounjaro,Bexagliflozin,Tirzepatide,Semaglutide 7.2 mg,Eli Lilly,CHMP review If you want,type 2 diabetes,Acromegaly,Endocrinology News,Abbott,DebiopharmBiorep Technologies,SNBTS

This biweekly endocrinology video recap covers major regulatory decisions,…

by LucidQuest

Obesity Weekly News

Obesity Today—December 16, 2025

December 16, 2025wegovy,semaglutide,BioPharma and Tech News,Novo Nordisk,Zepbound,Eli Lilly,GLP-1 receptor agonist,oral GLP-1,Obesity Newstriple agonist,retatrutide

Explore this week’s obesity highlights, including new developments, pipeline…

by LucidQuest

Endocrinology

Endocrinology Today—December 16, 2025

December 16, 2025semaglutide,BioPharma and Tech News,Tirzepatide,type 2 diabetes,Insulin Resistance,GLP-1 Receptor Agonists,Endocrinology News,gut microbiome,Continuous Glucose MonitoringChronic inflammation,ADA Standards of Care

Catch up on this week’s endocrinology highlights—from major developments and…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.